Introduction {#S4}
============

Although there is a general awareness about the negative consequences on health of being obese, the obesity rate (body mass index (BMI) ≥30 kg/m^2^) continues to increase. The increase in BMI is mainly considered to originate from behavioral and environmental changes, such as high caloric intake and a sedentary lifestyle.^[@R1]^ Nevertheless, a large proportion of the variation in BMI is still estimated to be influenced by genetic variants, as witnessed by a reported heritability of \~70%.^[@R2]^ Recent large-scale meta-analyses of genome-wide association studies have identify numerous genetic variants associated with BMI. Since the identified loci are estimated to account for only a small part of the variance in BMI, adding these small effects together into an obesity genetic risk score (OGRS) has been proposed to better capture these genetic effects.^[@R3]^ Studies evaluating both environmental and genetic influences on BMI trajectory across adulthood are rare, and to our knowledge no previous study has jointly studied these influences on BMI trajectory in midlife and late life.

Further, in late life, both low weight (often including normal weight) and weight decline is often associated with negative health outcomes.^[@R4],\ [@R5]^ This change, referred to as the obesity paradox, may be driven by weight loss primarily caused by disease processes occurring in late life. Hence, BMI and changes in BMI may be indicative of various processes across the life course, and thus may have different implications for health at different ages.

The aims of this study were to characterize the adult BMI trajectory and to analyze the influence of assessed genetic risk, lifestyle factors, and cardiometabolic diseases on the BMI trajectory at various stages of life. Data capturing up to 65 years of the adult lifespan were derived from two substudies of the Swedish Twin Registry (STR)^[@R6]^: TwinGene^[@R6]^ and the Swedish Adoption/Twin Study of Aging (SATSA).^[@R7]^

Methods {#S5}
=======

Design/participants {#S6}
-------------------

Both TwinGene and SATSA originate from the STR.^[@R6]^ The STR conducted mailed questionnaires in 1961, 1963, 1967, and 1970 for all like-sexed twins born between 1886 and 1925, and in 1973 for all like-sexed pairs born in 1926--1958 ([Figure 1](#F1){ref-type="fig"}). A more recent STR wave contacted adult twins via the Screening Across the Lifespan Twin study (1998--2002), which targeted all twins born in 1958 or earlier.

For TwinGene, which took place between 2004 and 2008, 12,614 twins who had previously taken part in the Screening Across the Lifespan Twin study donated a blood sample during in-person testing (IPT).^[@R6]^ Of the TwinGene participants, 6,130 persons were associated with a BMI value and information on all covariates.

SATSA, which has been described elsewhere,^[@R7]^ is a longitudinal study with repeated IPTs. For the current analyses, seven IPTs (from 1986 to 2007) were available. A total of 859 persons had participated in at least one IPT. Of these, 644 individuals (those participating in IPT3 or IPT5) had available genotyping, and 536 had information on all covariates.

Ethic statement {#S7}
---------------

TwinGene and SATSA have been approved by the ethics review board at Karolinska Institutet, Stockholm, Sweden. Informed consent was obtained from all participants.

BMI measurements {#S8}
----------------

BMI scores were calculated as kg/m^2^. In addition to height and weight measurements taken in person, or through the STR (self-reported), the 1886--1925 cohort also retrospectively self-reported their height and weight at 25 years and 40 years of age ([Figure 1](#F1){ref-type="fig"}). Through the STR alone, information on BMI is available for one-four occasions, depending on whether the twin belonged to the 1886--1925 cohort or to the 1926--1958 cohort. Thus, up to seven total assessments of height and weight were available for the TwinGene participants. SATSA participants had their height and weight assessed at least once, for a maximum of seven times through IPT. Combining the STR and SATSA data led to the availability of up to 12 BMI assessments in total. Mode of assessment was included as a covariate: (0=assessed in person, 1=self-reported, 2=retrospectively self-reported).

OGRS and genotyping {#S9}
-------------------

SATSA participants were genotyped with the Human Cardio-Metabo beadchip, and TwinGene participants were genotyped with the Illumina HumanOmniExpress 700K BeadChip. For 23 of 32 SNPs, the SNP was directly genotyped on the Metabochip; 28 of the 32 SNPs were directly genotyped on the OmniExpress. For the remaining loci, genotype information was imputed using a) a proxy SNP in high linkage disequilibrium with the reported SNP that was selected from a SNAP search^[@R8]^ (nine SNPs in SATSA); b) using IMPUTE2.0 (one SNP in TwinGene); or c) using the reported population frequency from a reference (three SNPs in TwinGene).^[@R9]^ The directly genotyped SNPs had a genotyping success of ≥99.4%. Exact Hardy-Weinberg equilibrium *P*-values were calculated using PLINK^[@R10]^, and all 32 SNPs had *P*-values \>0.005. In order to estimate the cumulative effect of the 32 BMI loci, we calculated individual non-weighted OGRS (*i.e.* count of increasing alleles) and weighted OGRS, using beta coefficients from Speliotes et al.^[@R9]^

Demographic factors, cardiometabolic risk factors, and diseases {#S10}
---------------------------------------------------------------

Educational level was coded as elementary school (0) or greater (1), and cohort was dichotomized as born between 1900--1925 (0) or 1926--1948 (1). Number of children was self-reported and entered as a mean-centered variable, at 2.1 in TwinGene and at 2.0 in SATSA. Based on self-reporting in the STR assessments (1967 or 1973), exercise was dichotomized as moderate to heavy exercise (0) and no or little exercise (1), and consumption of fruit and vegetables was divided into high (0) or low fruit consumption (1). Smoking status and alcohol consumption were based on self-reports from the STR and on first responses in SATSA IPT or TwinGene; these factors were dichotomized as never smoked (0) and had ever smoked (1), and as abstainers (never reported drinking alcohol, 0) and drinkers (1), respectively.

Data on cardiovascular diseases (CVD; stroke, myocardial infarction, heart failure, and angina pectoris) were extracted from the Swedish National Patient Register. Information on CVD and dementia was extracted from the National Patient Registry and the Cause of Death Register using the twins' personal identification numbers; the information was based on the International Classification of Disease (ICD). Only main diagnoses were considered for cardiovascular outcomes. For stroke, the following ICD codes were used: ICD-8 codes 430--436, ICD-9 codes 430--436, and ICD-10 codes I60--I64 and G45. For coronary heart disease (myocardial infarction and angina pectoris), we used ICD-8 codes 410 and 411, ICD-9 codes 410 and 411B, and ICD-10 codes I20.0, I21, and I22. For heart failure, we considered ICD-8 codes 427.00 and 427.10, ICD-9 code 428, and ICD-10 code I50. The ICD codes used to detect Alzheimer's disease were codes 304 and 305 (ICD-7), 290 (ICD-8), 290.0, 290.1, and 331.0 (ICD-9), and F00 and G30 (ICD-10). The ICD codes used to detect vascular dementia were codes 306 (ICD-7), 293.0 and 293.1 (ICD-8), 290.4 (ICD-9), and F01 (ICD-10). Additional ICD codes used to detect dementia were codes 294.1, 290.8, 290.9, 331.1, 331.2, and 331.9 (ICD-9), and F02, F03, G31.1, G31.8A, and F05.1 (ICD-10).

Hypertension was defined as resting systolic blood pressure above 140 mmHg and/or diastolic blood pressure above 90 mmHg in TwinGene or at least two stable measurements during the study period in SATSA, and/or self-reported use of antihypertensive medication. Presence of any of these disorders was summed into a CVD score (range, 0--5). Type 2 diabetes mellitus (T2DM) was based on self-reports of T2DM and/or diabetic agents and coded as absence (0) or presence (1) of T2DM across the study period.

Cancer diagnoses were extracted from the cancer registry and the cause of death registry, based on the following ICD-codes: 153, 154, 170, and 177 (ICD-7 and ICD-8), 153, 154, 159, 174, and 185 (ICD-9), and C180--C189, C199, C209--C211, C260, C500--C509, and C619 (ICD-10). Cancer was coded as absence (0) and presence (1). Information about asthma, bronchitis, and tuberculosis were self-reported in SALT (for TwinGene) and across the study in SATSA and coded as absence (0) or presence (1) of respiratory disease across the study period. Participants were continuously screened for dementia throughout SATSA^[@R11]^ and were diagnosed according to the relevant *Diagnostic and Statistical Manual of Mental Disorders* (Appendix 2). Dementia status was updated from the National Patient Register for subjects who were lost to follow-up in SATSA, and for all participants in TwinGene.

Statistical analysis {#S11}
--------------------

Baseline characteristics were analyzed in IBM SPSS statistics v. 21. Characterization of the BMI trajectory across the adult lifespan was performed first with SATSA data which includes up to twelve measurement points of BMI, and then confirmed with TwinGene data which includes fewer measurement points. This was done using SAS 9.3 (PROC MIXED, NLMIXED) and MPLUS^[@R12]^ using full-maximum likelihood estimation. Initial inspection of raw BMI trajectories ([figure 2](#F2){ref-type="fig"}) and model-fitting analyses in PROC MIXED suggested nonlinear curves fitted the data best. Follow-up analyses, in PROC NLMIXED estimated a cubic model with age, age-squared and age-cubed terms where the centering of age was estimated as a parameter, and represented the first turning point in the BMI curve. Results suggested the first turning point was at ages 65.4 years and 65.8 years in men and women, respectively. Next, in MPLUS we fitted a series of nested linear and piecewise (spline) growth models that captured up to two turning points and directly compared models between men and women.^[@R13],\ [@R12]^ Age predictors were centered at the first turning point of 65 years. The best-fitting model chosen for further analysis was a piecewise model with three linear age-based trends: slope A (25 years to \<65 years), slope B (≥65 years to \<80 years), and slope C (≥80 years). Given that there were fewer assessments of BMI in late life in TwinGene, a two-part linear piecewise model was chosen, with a single change point at 65 years of age.

All subsequent growth models were run separately for men and women. Models were adjusted to account for within and between twin pair effects. Assessment type effects on the intercept and slopes were evaluated (i.e., retrospective self-report, concurrent self-report, or assessed weights), and found to be nonsignificant for the slopes, but not for the intercept. Hence, all models controlled for assessment type for the intercept. Previous analyses on SATSA have shown that retrospectively self-reported weight captures the population mean,^[@R14]^ and the accuracy of self-reported height and weight does not change substantially over time.^[@R15]^ This strengthens the assumption that potential errors due to report bias mainly affects the mean level and less so the trajectory shape.

Separately for TwinGene and SATSA, and separately for men and women, a stepwise procedure was adopted to evaluate the influence of various factors based on occurrence in time: OGRS, birth cohort, education, number of children, lifestyle factors, and diseases. For each factor, the effect was first evaluated on the intercept and then on the A and B (and C, for SATSA data) slopes. The summed OGRS was chosen for further analysis as it received a better fit than the weighted OGRS, based on the −2Log Likelihood test. Predictors with a significant effect (*P*≤0.05), when the main effect and interaction effects were entered, on the intercept or on any of the trajectories were carried on to the next step. In the final model, birth cohort and education were included as well as those factors that exerted an effect on the average BMI or on a specific linear term within sex, in either of the two studies.

Non-independency within and between twin pairs were controlled for in all models. BMI assessment mode was evaluated and found to be significant for the intercept, but not for the slopes. Hence, all models controlled for assessment mode on the intercept. Latent growth model analyses were performed in MPLUS^[@R12]^ and SAS 9.3,^[@R16]^ using full maximum-likelihood estimation.^[@R17]^

Results {#S12}
=======

Participant characteristics are presented in [Table 1](#T1){ref-type="table"}. The best-fitting model, which was based on SATSA, was a three-spline model with an increase in BMI from age 25 years to age 65 years. After age 65 years, the increase leveled out and started to decline after the age of 80 years. The number of persons that had at least one assessment of BMI before and after the breakpoints was 49.1% (n = 263) before and after 65 years and 20.9% (n = 112) before and after 80 years. General BMI trajectories for men and women and study are presented in [Figure 3a](#F3){ref-type="fig"}.

The final model is presented separately for men ([Table 2](#T2){ref-type="table"}) and for women ([Table 3](#T3){ref-type="table"}). Unless otherwise indicated, the results were consistent across the studies. BMI trajectories based on birth cohort, genetic risk of obesity, and prevalence of T2DM are presented in [Figure 3b--d](#F3){ref-type="fig"}.

Men {#S13}
---

For men, being born after 1925, having a higher OGRS, having T2DM, and having CVD were independently associated with higher average BMI. All of these factors (except CVD) were also associated with a steeper increase in BMI until the age of 65 years. Furthermore, higher intake of alcohol (compared to being an abstainer) was associated with a steeper increase in BMI until the age of 65 years. After age 65, no consistent patterns were found across the studies for men.

Some differences between the two studies were noticed. In TwinGene, men who smoked had a higher BMI and a steeper increase in BMI until the age of 65 years. Men with a higher educational level had a steeper increase in BMI until the age of 65 years, and a steeper decrease in BMI after the age of 65 years, compared to persons with lower education. In SATSA, after the age of 80 years, men with higher educational levels had a smaller decrease in BMI than those with lower educational levels. Further, men with cancer had a less steep increase in BMI until the age of 65 years, while men with respiratory disease had a higher BMI at the age of 65 years and until the age of 65 years. This was not replicated in SATSA.. Exercise was not significantly associated with the BMI trajectory when all other factors were considered.

Women {#S14}
-----

Across both studies, T2DM and CVD were independently associated with a higher average BMI and with a steeper increase in BMI until the age of 65 years ([Table 3](#T3){ref-type="table"}). Women who smoked had a lower average BMI and a less steep increase in BMI until the age of 65 years than women who did not smoke. A higher OGRS was associated with higher mean BMI and a steeper BMI increase up to age 65 years in TwinGene, but not in SATSA. In TwinGene, the cohort born after 1925 had a higher mean BMI, but in SATSA this difference did not achieve statistical significance. However, in both studies women born after 1925 had a steeper increase in BMI until the age of 65 years. Further, women who had given birth to a higher number of children had a higher mean BMI at the age of 65 years, and steeper increase in BMI until the age of 65 years.

Between ages 65 and 80 years, women who smoked had a steeper increase in BMI and women with T2DM had a steeper decline in BMI. Dementia was associated with lower mean BMI in TwinGene and a less steep increase in BMI until the age of 65 years, and in SATSA dementia was associated with a steeper decline in BMI between the ages of 65 and 80 years. Education was not significantly associated with BMI in either study after entering all other factors.

Discussion {#S15}
==========

Although it has previously been suggested that a turning point in BMI may occur late in life,^[@R18]^ our study covering the adult life course demonstrates that there are two turning points in BMI in late life, one at 65 years and another at 80 years. BMI increases across midlife, the increase levels off after the age of 65 years and BMI then declines around the age of 80 years. While genetic factors, birth cohort, and cardiometabolic diseases generally predicted higher average BMI and a steeper increase in BMI in midlife among both men and women, decrease in BMI after the age of 65 years was predicted by T2DM and dementia, among women.

Turning points in BMI in late life {#S16}
----------------------------------

Weight decline in late life is proposed to be driven by disease processes^[@R4]^ and mortality.^[@R19],\ [@R20]^ We found that diseases with increasing incidence in late life such as T2DM and dementia were associated with decline in BMI in late life, especially among women. Among the 80 years old and older, more than 50% have multimorbidity.^[@R21]^ Pathophysiological processes, for example those causing metabolic changes or behavioral changes, and/or drug side effects probably contribute to weight decline seen in late life, and subsequent death. Nonetheless, studies controlling for multimorbidity^[@R20],\ [@R22]^ still show an association between decline in BMI and mortality. Other factors, such as poorer psychological well-being, including loss of appetite, or the body's inability to take up and benefit from nutrients might also be on the causal pathway.

Genetic risk score for obesity {#S17}
------------------------------

Studies based on children and young adults have shown that the fat mass and obesity associated gene (*FTO*) and constructed OGRSs predict accelerated increases in BMI.^[@R23]--[@R25]^ We find that this predictive relationship holds true through the midlife period, but not in late life. However, our findings are not in accordance with a study including participants from five European countries in which *FTO* was not found to be associated with a change in weight over seven years in midlife.^[@R26]^ It is possible that the influence of obesity genes can only be detected with a longer follow-up time, or by evaluating several genetic variants together, as we did. The OGRS was not associated with a change in BMI in late life ([Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}). Hence, it may be that other genetic variants, including those associated with late-life diseases, are more important for BMI changes in late life. Genome-wide association studies of elderly populations that focus on change, and not just cross-sectional analyses, could add valuable knowledge about the less well-understood origins of weight changes in late life.

Cohort differences {#S18}
------------------

We found generational differences in BMI where the later born cohort had higher BMI. These birth cohort differences are often suggested to be due to changes in lifestyle, specifically higher caloric intake and less physical activity. However, neither physical exercise nor high intake of fruit and vegetables (a rough proxy for a healthy diet) were associated with average BMI or with change in BMI when all factors were considered ([Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}). The observed influence of birth cohort may instead reflect trends that are difficult to assess, such as decreased overall lower energy expenditure or increased use of caloric sweeteners.^[@R27]^

Cohorts born after1925 gained weight at a steeper rate in midlife. Interestingly, persons born before 1926 were heavier in early midlife ([Figure 3b](#F3){ref-type="fig"}), especially women. One possible explanation for this result is that persons born before 1926 had more physically demanding lives, for example by being a farmer or a farmer's wife, which were very common occupations during the first half of the 20^th^ century in Sweden. Within the normal BMI range, greater muscle mass results in a higher BMI. For women, cohort differences may also be associated with childbirth patterns; the cohorts born before 1926 had more children and also gave birth earlier in life. In fact, women who had given birth to more children experienced a steeper increase in BMI until the age of 65 years, and a higher BMI at the age of 65 years, than women who had given birth to fewer children. Reasons for the steeper weight gain among women who have given birth is probably multifactorial. For example, women who have given birth (and more births) may not be able to return to pre-birth weights as easily and hence accumulate weight for each successive birth. Further, the reproductive years might be associated with lower physical activity^[@R28],\ [@R29]^ and dietary changes.^[@R29]^

While the cohort difference in BMI was preserved in late life for men, for women, both the level of BMI and the BMI trajectories were strikingly similar for both cohorts after the age of 65 years. Rapid weight gain during midlife has been suggested to have health consequences as negative as having a consistently higher BMI, or even worse.^[@R30]^ Hence, the negative effects of weight gain may have occurred earlier and ultimately caused weight loss, bringing the subjects to the same level of BMI as the earlier born cohort. The women in TwinGene who were born before 1926 exhibited a different growth pattern from the other female trajectories. Their pattern most likely reflects a selection effect, as the youngest persons in this cohort were 79 years old when data collection for the TwinGene study started.

Disorders {#S19}
---------

In the presence of genetic and lifestyle factors, CVD and T2DM were still strongly associated with a higher mean BMI and a steeper increase in BMI until the age of 65 years ([Table 2](#T2){ref-type="table"}, [Table 3](#T3){ref-type="table"}, and [Figure 3c](#F3){ref-type="fig"}). Accordingly, both high average BMI and increase in BMI across midlife should be seen as important risk factors for lifetime cardiometabolic disease. Both in clinical practice and in research, weight changes, and not only current BMI, should be considered when health risks are evaluated.

Obesity has been suggested as a potential risk factor for cancer of different types.^[@R31],\ [@R32]^ The association between cancer and BMI is complex, and is dependent on the age of exposure and cancer type,^[@R33]^ as indicated in the current study. While cancer was associated with a less steep increase in BMI until the age of 65 years among men in TwinGene, no such association was found among women or the men in SATSA. It is possible that reversed causality influences the association between BMI and cancer in TwinGene, as weight loss BMI might be an indication of underlying cancer, as has been reported for prostate cancer, for example.^[@R33]^

Although not consistently observed as significant across the studies, respiratory diseases were associated with higher BMI at age 65 years and steeper increase in BMI until the age of 65 years. Higher BMI might be a risk factor for respiratory diseases, as adiposity might affect the function of the respiratory system.^[@R34]^ However, higher BMI and weight gain might also be a consequence of the medical treatment of respiratory diseases, for example with steroids.^[@R35]^

Lifestyle factors {#S20}
-----------------

The lifestyle factors that were most strongly associated with BMI and the BMI trajectories were not consistent across age or sex. As previously shown,^[@R36]^ among men, alcohol use was especially associated with a steeper increase in BMI during midlife ([Table 2](#T2){ref-type="table"}), which likely is related to increased energy intake. Among women, smoking was associated with lower BMI and a lower increase in BMI until the age of 65 years ([Table 3](#T3){ref-type="table"}), confirming previous findings.^[@R37]^ In the presence of genetic factors and disease, few other lifestyle factors were associated with either the average BMI or the BMI curve; this observation was particularly true for changes in BMI in old age ([Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}). Studies focusing on weight changes in late life are therefore warranted.

Strengths and limitations {#S21}
-------------------------

The strengths of this study include a population-based design with rich assessments of multiple factors over a long follow-up. However, the societal changes occurring over this timeframe with respect to lifestyle factors limits the generalizability of these results to more recent birth cohorts. The stability of the change points needs to be discussed, as there is a gap in measurements. This is more so a problem in TwinGene than in SATSA. Therefore, we characterized the adult BMI curve on SATSA where almost 50% of the sample had data before and after the first change point at 65 years and similarly about 20% of the sample had data around the second change point at 80 years. Thorough analyses confirmed these findings, among both men and women.

Another limitation is that different assessment methods of height and weight were used. BMI values bases on self-reported height and weight usually result in an underestimation of the actual BMI.^[@R38]^ The influence of different assessment methods would particularly influence the expected BMI levels at the change points between the assessment methods, as we have previously shown that the change in self-report bias is small to negligible over time.^[@R15]^ Still, the use of self-reported BMI in early midlife likely underestimates actual BMI, hence, a flatter BMI trajectory from early midlife to late midlife would be expected if height and weight were measured. However, given the careful control of the influence of assessment methods in the analysis, we do believe that the impact of the assessment methods is small and does not substantially influence the results.

All evaluated lifestyle factors were self-reported, and we lacked sufficient coverage to evaluate these behaviors as time-varying covariates. Similarly, the National Patient Register did not cover all parts of Sweden until 1987, and we were therefore not able to differentiate between early and late onset T2DM and CVD.

Conclusions {#S22}
-----------

There are two turning points in BMI in adulthood, one at age 65 years and one at age 80 years. While genetic factors, birth cohort, and cardiometabolic diseases generally predicted higher average BMI and a steeper increase in BMI in midlife, after age of 65 years T2DM and dementia predicted decline in BMI. This study shows that the factors influencing change in BMI differ across the adult life course. Current health recommendations need to be adjusted accordingly.
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![Raw trajectories of BMI.\
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###### 

Sample Characteristics, Total Sample and by Sex.

                                                                         TwinGene      SATSA                                                 
  ---------------------------------------------------------------------- ------------- ------------- ------------- ------------ ------------ ------------
  Age in years at IPT~entry~,[a](#TFN1){ref-type="table-fn"} mean (SD)   64.8 (8.1)    64.8 (8.1)    65.5 (8.0)    61.4 (8.1)   60 (6.6)     62.0 (8.7)
  BMI kg/m^2^ at IPT~entry~, mean (SD)                                   25.9 (3.9)    25.9 (3.9)    26.1 (3.4)    25.7 (3.9)   25.9 (3.3)   25.5 (4.3)
  Older cohort, n (%)                                                    297 (4.8)     138 (4.9)     159 (4.8)     239 (44.6)   100 (44.1)   139 (45.0)
  Education ≤6 years, n (%)                                              1194 (19.5)   609 (21.4)    585 (17.8)    317 (59.1)   126 (55.5)   191 (61.8)
  Genetic risk score, mean (SD)                                          28.6 (3.4)    28.6 (3.4)    28.6 (3.4)    28.9 (3.7)   29.0 (3.6)   28.9 (3.8)
  Number of children, mean (SD)                                          2.1 (1.0)     1.9 (1.1)     2.3 (0.9)     2.0 (1.4)    1.9 (1.5)    2.1 (1.4)
  [**Midlife lifestyle factors**]{.ul}                                                                                                       
  No/light exercise, n (%)                                               1200 (19.6)   469 (16.5)    731 (17.8)    153 (28.5)   56 (24.7)    97 (31.4)
  Low intake fruit and veg., n (%)                                       1589 (25.9)   1004 (35.5)   585 (17.8)    277 (51.7)   140 (61.7)   137 (44.3)
  Never smoked, n (%)                                                    2744 (44.8)   1187 (41.8)   1557 (47.4)   263 (49.1)   67 (29.5)    196 (44.3)
  Alcohol abstainers, n (%)                                              356 (5.8)     122 (4.3)     234 (7.1)     80 (14.9)    20 (8.8)     60 (31.4)
  [**Diseases (across the study period)**]{.ul}                                                                                              
  T2DM, n (%)                                                            561 (9.2)     342 (12.0)    219 (6.7)     92 (17.2)    41 (18.1)    51 (16.1)
  CVD, n (%)[b](#TFN2){ref-type="table-fn"}                              3380 (55.1)   1350 (60.1)   1470 (50.8)   209 (39.0)   104 (45.8)   105 (34.0)
  Cancer, n (%)                                                          434 (7.0)     234 (8.7)     200 (6.1)     60 (11.2)    32 (14.1)    28 (9.1)
  Lung disease, n (%)[c](#TFN3){ref-type="table-fn"}                     550 (9.0)     218 (8.1)     332 (10.1)    120 (22.1)   47 (20.7)    73 (23.7)
  All-cause dementia, n (%)                                              93 (1.5)      45 (1.6)      48 (1.5)      62 (11.6)    18 (7.9)     44 (14.2)

Age at the first in-person testing of BMI

Prevalence of one or more CVD (stroke, angina pectoris, heart failure, myocardial infarction, and/or hypertension)

Prevalence of one lung disease (asthma, bronchitis, and/or tuberculosis)

###### 

Factors Associated with the BMI Trajectory from Age 25 Years to Late Life in Men: Final Model Results

                                                  TwinGene   SATSA                                
  ----------------------------------------------- ---------- --------- --------- -------- ------- ---------
  Intercept (age 65 years)                        24.904     0.457     \<0.001   24.177   0.882   \<0.001
  Slope A (age 25--65 years)                      0.029      0.011     0.011     0.017    0.021   0.410
  Slope B (age \>65--80 years)                    −0.007     0.021     0.727     0.046    0.026   0.084
  Slope C (age \>80 years)                        \-         \-        \-        −0.178   0.055   0.001
  [**Demographic**]{.ul}                                                                          
  Assessment bias                                 −0.206     0.039     \<0.001   −0.298   0.138   0.031
  Cohort                                          0.615      0.358     0.086     2.303    0.490   \<0.001
  Cohort\*Slope A                                 0.026      0.009     0.004     0.052    0.012   \<0.001
  Cohort\*Slope B                                 0.027      0.020     0.193     −0.009   0.036   0.792
  Cohort\*Slope C                                 \-         \-        \-        \-       \-      \-
  Education                                       −0.037     0.156     0.814     −0.503   0.411   0.221
  Education\*Slope A                              0.020      0.004     \<0.001   −0.010   0.011   0.345
  Education\*Slope B                              −0.038     0.017     0.022     −0.023   0.035   0.497
  Education\*Slope C                              \-         \-        \-        0.231    0.108   0.033
  [**Genetic**]{.ul}                                                                              
  OGRS                                            0.085      0.019     \<0.001   0.148    0.055   0.007
  OGRS\*Slope A                                   \<0.001    \<0.001   0.251     0.003    0.001   0.038
  [**Midlife lifestyle factors**]{.ul}                                                            
  Exercise                                        −0.072     0.101     0.473     −0.356   0.333   0.285
  Smoking                                         0.270      0.125     0.031     −0.152   0.432   0.724
  Smoking\*Slope A                                0.010      0.003     0.002     −0.008   0.012   0.528
  Alcohol                                         0.601      0.287     0.037     0.574    0.687   0.403
  Alcohol\*Slope A                                0.024      0.008     0.002     0.043    0.019   0.025
  [**Diseases (across the study period)**]{.ul}                                                   
  T2DM                                            1.966      0.184     \<0.001   2.380    0.510   \<0.001
  T2DM\*Slope A                                   0.023      0.005     \<0.001   0.041    0.013   0.002
  T2DM\*Slope B                                   −0.008     0.022     0.727     −0.107   0.041   0.009
  CVD                                             0.164      0.042     \<0.001   0.301    0.219   0.170
  Cancer                                          −0.358     0.210     0.089     0.877    0.508   0.085
  Cancer\*Slope A                                 −0.013     0.006     0.015     −0.006   0.014   0.669
  Respiratory diseases                            0.570      0.209     0.006     −0.031   0.461   0.947
  Respiratory diseases\*Slope A                   0.017      0.005     0.001     −0.008   0.012   0.497

Slope A (25 years to \<65 years), slope B (≥65 years to \<80 years), and slope C (≥80 years)

###### 

Factors Associated with the BMI Trajectory from Age 25 Years to Late Life in Women: Final Model Results

                                                  TwinGene   SATSA                                 
  ----------------------------------------------- ---------- -------- --------- ---------- ------- ---------
  Intercept (age 65 years)                        23.9314    0.494    \<0.001   24.614     0.795   \<0.001
  Slope A (age 25--65 years)                      0.038      0.012    0.001     0.065      0.020   0.001
  Slope B (age \>65--80 years)                    0.018      0.027    0.503     0.052      0.031   0.086
  Slope C (age \>80 years)                        \-         \-       \-        −0.030     0.091   0.746
  [**Demographic**]{.ul}                                                                           
  Assessment bias                                 −0.453     0.046    \<0.001   −0.142     0.149   0.339
  Cohort                                          1.756      0.467    \<0.001   1.052      0.679   0.123
  Cohort\*Slope A                                 0.074      0.011    \<0.001   0.056      0.015   \<0.001
  Cohort\*Slope B                                 −0.030     0.032    0.362     −0.124     0.044   0.005
  Cohort\*Slope C                                 \-         \-       \-        \-         \-      \-
  Education                                       −0.014     0.210    0.947     0.216      0.548   0.694
  Education\*Slope A                              0.009      0.005    0.083     0.021      0.014   0.117
  Education\*Slope B                              −0.037     0.023    0.114     0.045      0.035   0.193
  Education\*Slope C                              \-         \-       \-        −0.071     0.125   0.569
  Children                                        0.391      0.077    \<0.001   0.097      0.172   0.571
  Children\*Slope A                               0.005      0.001    0.006     0.003      0.004   0.495
  [**Genetic**]{.ul}                                                                               
  OGRS                                            0.128      0.024    \<0.001   0.064      0.068   0.346
  OGRS\*Slope A                                   0.001      0.0005   0.024     \<−0.001   0.002   0.833
  [**Midlife lifestyle factors**]{.ul}                                                             
  Fruit and Veg.\*Slope B                         0.058      0.029    0.046     0.058      0.037   0.117
  Smoking                                         −0.405     0.156    0.010     −1.499     0.508   0.003
  Smoking\*Slope A                                −0.007     0.004    0.072     −0.025     0.013   0.051
  Smoking\*Slope B                                0.014      0.023    0.534     0.083      0.034   0.015
  Alcohol\*Slope C                                \-         \-       \-        −0.236     0.110   0.031
  [**Diseases (across the study period)**]{.ul}                                                    
  T2DM                                            3.006      0.299    \<0.001   1.913      0.699   0.006
  T2DM\*Slope A                                   0.054      0.007    \<0.001   0.045      0.017   0.009
  T2DM\*Slope B                                   −0.022     0.036    0.542     −0.103     0.040   0.009
  CVD                                             0.659      0.104    \<0.001   0.894      0.424   0.035
  CVD\*Slope A                                    0.010      0.002    \<0.001   0.020      0.011   0.066
  Respiratory disease                             0.803      0.238    0.001     0.663      0.534   0.215
  Respiratory disease\*Slope A                    0.016      0.238    0.005     −0.002     0.014   0.883
  Dementia                                        −1.540     0.675    0.022     0.348      0.742   0.639
  Dementia\*Slope A                               −0.041     0.019    0.029     −0.007     0.019   0.712
  Dementia\*Slope B                               0.057      0.047    0.225     −0.119     0.043   0.006

Slope A (25 years to \<65 years), slope B (≥65 years to \<80 years), and slope C (≥80 years)
